• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球 2012-2021 年非酒精性脂肪性肝病治疗趋势:文献计量学和图谱分析。

Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis.

机构信息

The Fourth Affiliated Hospital of China Medical University, Shenyang, 110000, Liaoning, China.

出版信息

Endocr Metab Immune Disord Drug Targets. 2024;24(5):573-584. doi: 10.2174/0118715303230418230925060312.

DOI:10.2174/0118715303230418230925060312
PMID:37855283
Abstract

AIM

The present study aimed to map publication trends and explore research hotspots of treatment for NAFLD study by bibliometric analysis.

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is a multi-system metabolic disorder involving the liver. Thousands of papers have been published on the treatment of NAFLD, but no comprehensive statistical and intuitive analysis has been made. The present study aimed to map publication trends and explore research hotspots of treatment for NAFLD study by bibliometric analysis.

OBJECTIVE

(1) The pathogenesis of NAFLD and the possible treatment mechanism; (2) prevalence, risk factors, and traditional therapies for NAFLD; (3) frontier therapies for NAFLD. Method; This paper conducted a bibliometric analysis based on the Web of Science Core Collection (WoSCC). The knowledge map was constructed by VOS viewer v.1.6.10 to visualize the annual publication number, the distribution of countries, international collaborations, author productivity, source journals, cited references, and keywords in this field.

RESULTS

From 2012 to 2021, 2,437 peer-reviewed publications on the treatment of NAFLD were retrieved. China contributed the most publications, while the United States received the most citations. Journal of Hepatology was the most prolific journal in this field. Prof. Rohit Loomba.

CONCLUSION

Our study provides a comprehensive and objective analysis of NAFLD treatment that allows researchers to quickly locate research hotspots in a large number of relevant literatures. Meanwhile, it may also provide valuable information for researchers looking for potential partners and institutions.

摘要

目的

本研究旨在通过文献计量分析绘制非酒精性脂肪性肝病(NAFLD)治疗研究的发表趋势图,并探讨研究热点。

背景

非酒精性脂肪性肝病(NAFLD)是一种涉及肝脏的多系统代谢紊乱疾病。已经发表了数千篇关于 NAFLD 治疗的论文,但尚未对此进行全面的统计和直观分析。本研究旨在通过文献计量分析绘制 NAFLD 治疗研究的发表趋势图,并探讨研究热点。

目的

(1)NAFLD 的发病机制及可能的治疗机制;(2)NAFLD 的患病率、风险因素和传统疗法;(3)NAFLD 的前沿疗法。方法:本研究基于科睿唯安的 Web of Science 核心合集(WoSCC)进行了文献计量分析。使用 VOSviewer v.1.6.10 构建知识图谱,可视化该领域的年发文量、国家分布、国际合作、作者生产力、来源期刊、被引参考文献和关键词。

结果

从 2012 年到 2021 年,共检索到 2437 篇关于 NAFLD 治疗的同行评议出版物。中国发表的文献数量最多,而美国获得的引用次数最多。《肝脏病学杂志》是该领域最具影响力的期刊。Rohit Loomba 教授。

结论

本研究对 NAFLD 治疗进行了全面客观的分析,使研究人员能够在大量相关文献中快速定位研究热点。同时,它也可能为寻找潜在合作伙伴和机构的研究人员提供有价值的信息。

相似文献

1
Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis.全球 2012-2021 年非酒精性脂肪性肝病治疗趋势:文献计量学和图谱分析。
Endocr Metab Immune Disord Drug Targets. 2024;24(5):573-584. doi: 10.2174/0118715303230418230925060312.
2
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023).全球非酒精性脂肪性肝病治疗的趋势和热点:文献计量学和可视化分析(2010-2023)。
World J Gastroenterol. 2023 Oct 7;29(37):5339-5360. doi: 10.3748/wjg.v29.i37.5339.
3
Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis.非酒精性脂肪性肝病(NAFLD)肠道-肝脏轴的全球发表趋势和研究热点:文献计量分析。
Front Endocrinol (Lausanne). 2023 Mar 9;14:1121540. doi: 10.3389/fendo.2023.1121540. eCollection 2023.
4
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis.绘制全球研究趋势图:营养与非酒精性脂肪性肝病的关联——Scopus 文献计量分析。
World J Gastroenterol. 2024 Jun 28;30(24):3106-3119. doi: 10.3748/wjg.v30.i24.3106.
5
Trends in Research Related to Keratoconus From 2009 to 2018: A Bibliometric and Knowledge Mapping Analysis.2009年至2018年圆锥角膜相关研究趋势:文献计量学与知识图谱分析
Cornea. 2019 Jul;38(7):847-854. doi: 10.1097/ICO.0000000000001984.
6
Mapping research trends of retinal vein occlusion from 2009 to 2018: a bibliometric analysis.2009年至2018年视网膜静脉阻塞的研究趋势图谱:一项文献计量分析
PeerJ. 2019 Aug 29;7:e7603. doi: 10.7717/peerj.7603. eCollection 2019.
7
A bibliometric analysis and visualization of nonalcoholic fatty liver disease from 2012 to 2021.2012年至2021年非酒精性脂肪性肝病的文献计量分析与可视化
Clin Exp Med. 2023 Oct;23(6):1961-1971. doi: 10.1007/s10238-023-01023-2. Epub 2023 Feb 16.
8
Unveiling global research trends and hotspots on mitochondria in NAFLD from 2000 to 2023: A bibliometric analysis.揭示 2000 年至 2023 年非酒精性脂肪性肝病中线粒体相关研究的全球趋势和热点:文献计量分析。
Immun Inflamm Dis. 2024 Mar;12(3):e1226. doi: 10.1002/iid3.1226.
9
Mapping the Evolution of Digital Health Research: Bibliometric Overview of Research Hotspots, Trends, and Collaboration of Publications in JMIR (1999-2024).绘制数字健康研究的演进图:JMIR(1999-2024 年)研究热点、趋势和出版物合作的文献计量学概述。
J Med Internet Res. 2024 Oct 17;26:e58987. doi: 10.2196/58987.
10
Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: A bibliometric analysis.2002 年至 2022 年胆汁酸与非酒精性脂肪性肝病相关性的研究趋势和热点:文献计量分析。
Endocrinol Diabetes Metab. 2024 Jan;7(1):e460. doi: 10.1002/edm2.460. Epub 2023 Nov 8.

引用本文的文献

1
Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysis.绘制全球研究趋势图:营养与非酒精性脂肪性肝病的关联——Scopus 文献计量分析。
World J Gastroenterol. 2024 Jun 28;30(24):3106-3119. doi: 10.3748/wjg.v30.i24.3106.

本文引用的文献

1
Bibliometric analysis of metabolic surgery for type 2 diabetes: current status and future prospects.代谢手术治疗 2 型糖尿病的文献计量分析:现状与未来前景。
Updates Surg. 2022 Apr;74(2):697-707. doi: 10.1007/s13304-021-01201-5. Epub 2022 Jan 30.
2
Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies.非酒精性脂肪性肝病中的炎症和纤维化机制-对新治疗策略的启示。
J Intern Med. 2022 Jan;291(1):11-31. doi: 10.1111/joim.13380. Epub 2021 Sep 26.
3
Mechanisms and disease consequences of nonalcoholic fatty liver disease.
非酒精性脂肪性肝病的机制及疾病后果
Cell. 2021 May 13;184(10):2537-2564. doi: 10.1016/j.cell.2021.04.015.
4
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease.非酒精性脂肪性肝病肝纤维化的临床评估与管理。
World J Gastroenterol. 2020 Oct 21;26(39):5919-5943. doi: 10.3748/wjg.v26.i39.5919.
5
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease.过氧化物酶体增殖物激活受体及其新型配体作为非酒精性脂肪性肝病治疗的候选药物。
Cells. 2020 Jul 8;9(7):1638. doi: 10.3390/cells9071638.
6
IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.IRE1A 刺激肝细胞来源的细胞外囊泡,促进脂肪性肝炎小鼠的炎症反应。
Gastroenterology. 2020 Oct;159(4):1487-1503.e17. doi: 10.1053/j.gastro.2020.06.031. Epub 2020 Jun 20.
7
Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.生物信息学分析揭示了与非酒精性脂肪性肝病和非酒精性脂肪性肝炎相关的新核心基因。
Gene. 2020 Jun 5;742:144549. doi: 10.1016/j.gene.2020.144549. Epub 2020 Mar 14.
8
Therapeutic Landscape for NAFLD in 2020.2020 年非酒精性脂肪性肝病的治疗性景观。
Gastroenterology. 2020 May;158(7):1984-1998.e3. doi: 10.1053/j.gastro.2020.01.051. Epub 2020 Feb 13.
9
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.非酒精性脂肪性肝病伴或不伴糖尿病患者的降糖药物疗效和安全性:一项更新的随机对照试验系统评价。
Diabetes Metab. 2020 Nov;46(6):427-441. doi: 10.1016/j.diabet.2019.12.007. Epub 2020 Jan 7.
10
The therapeutic potential of targeting tryptophan catabolism in cancer.靶向色氨酸分解代谢治疗癌症的潜力。
Br J Cancer. 2020 Jan;122(1):30-44. doi: 10.1038/s41416-019-0664-6. Epub 2019 Dec 10.